Sindbis virus
| Amiodarone | SINV | Non-competitive β-adrenergic inhibitor | Preclinical | — | Human (multiple) | |
| Amodiaquine | SINV | Methyltransferase inhibitor | Preclinical | — | Human HNMT | |
| Aprotinin | SINV | Serine protease inhibitor | Preclinical | — | Human (multiple) | |
| Berberine | SINV | AMP-activated protein kinase (AMPK) activator | Preclinical | — | Unknown | |
| Betulinic Acid | SINV | Unknown | Preclinical | — | Unknown | |
| Eflornithine | SINV | Enzyme-activated; irreversible inhibitor of ornithine decarboxylase | Preclinical | — | Human ODC | |
| Gemcitabine | SINV | Antimetabolite; Nucleoside analog | Preclinical | — | Viral RNA pol | |
| Ivermectin | SINV | Importin ?/?-mediated nuclear import inhibitor | Preclinical | — | Human importin | |
| Lanatoside C | SINV | Increasing the concentration of intracellular calcium | Preclinical | — | Unknown | |
| Mitoxantrone | SINV | Topoisomerase II inhibitor | Preclinical | — | Human topoisomerase | |
| Navitoclax | SINV | Bcl-2/Bcl-xL inhibitor | Preclinical | — | Human BCL2 | |
| Niclosamide | SINV | — | Preclinical | — | Human (multiple) | |
| Nitroprusside | SINV | Nitrix oxide donor | Preclinical | — | Human NPR1 | |
| Obatoclax | SINV | Bcl-2 family inhibitor | Preclinical | — | Human MCL1 | |
| Raloxifene | SINV | Selective estrogen receptor modulator | Preclinical | — | Human (multiple) | |
| Saliphenylhalamide | SINV | Human vATPase inhibitor | Preclinical | — | Human vATPase | |
| Sorafenib | SINV | B-Raf; FGFR-1; VEGFR-2 & -3; PDGFR-beta; KIT; and FLT3 inhibitor | Preclinical | — | Human PTK |